CA SR110

Proclaims the week of May 21, 2018, as Tardive Dyskinesia Awareness Week in California to raise awareness of this potentially debilitating disease.

Recognizes that Tardive Dyskinesia (TD) is a movement disorder characterized by involuntary movements affecting the face, trunk, extremities, and muscles involved in walking, speech, eating, and breathing.

Notes that TD can develop months, years, or decades after starting dopamine receptor blocking agents (DRBAs) used to treat serious mental illness and gastrointestinal disorders, with a 30-50 percent risk of developing TD after prolonged exposure.

Estimates over 60,000 Californians suffer from TD and emphasizes that regular screening and evaluation by healthcare providers is recommended by the American Psychiatric Association.

Acknowledges that two new FDA-approved treatments for TD were recently developed and that patients with TD often face social isolation due to embarrassment from involuntary movements.